Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zilentin AG
Deal Watch: OrsoBio Reveals Its Metabolic Health Focus With Four Licensing Pacts
California biotech also notes prior licensing deal with Gilead for mitochondrial candidate. Twentyeight-Seven acquires RNA-splicing cancer candidate from Basilea.
- Other Names / Subsidiaries
- Auris Medical Holding Ltd.
- Zilentin Ltd.
- Zilentin SA
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.